Thought Leadership
 
Email Page
Status Quo Maintained: FDA Reverses Course on Generic Product Labeling
March 1, 2019
Chad Landmon and Eric Dunbar
FDLI Update

Axinn partner Chad Landmon and associate Eric Dunbar authored the FDLI’s Update article, "Status Quo Maintained: FDA Reverses Course on Generic Product Labeling."

Click here to access the article. Shared with the permission of FDLI.